Arcapta Neohaler

Indicated For

COPD

About This Medication

# Novartis Patient Assistance Foundation, Inc. Patient Guide: How to Get Arcapta Neohaler (indacaterol) at Low or No Cost Arcapta Neohaler (indacaterol) is a long-acting beta2-adrenergic agonist (LABA) inhalation powder used once daily to help control symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The **Novartis Patient Assistance Foundation, Inc. (NPAF)** program provides **Arcapta Neohaler free of charge** to eligible patients who meet specific income, residency, insurance, and prescription criteria[1][2][3]. This guide explains everything you need to know to apply and get started. ## About Arcapta Neohaler (indacaterol) **Arcapta Neohaler** contains indacaterol, a bronchodilator that relaxes muscles in the airways to improve breathing in COPD patients. It's not a rescue inhaler for sudden symptoms and should be used as prescribed by your doctor. Common side effects include cough, runny nose, headache, and throat irritation. Always follow your healthcare provider's instructions and read the full prescribing information[10]. This medication can be expensive without assistance—often over $300 per month retail. The NPAF program helps uninsured or underinsured patients access it at **no cost** if approved[3][5]. ## Who Qualifies for the NPAF Program? To qualify for free **Arcapta Neohaler** through NPAF, you must: - Be a resident of the **United States or U.S. territory**[2][5]. - Have **limited or no prescription insurance coverage**; patients with **Medicare Part D are not eligible**[1][7]. No prescription coverage is required, but you cannot have active coverage that pays for Novartis medications[1][2]. - **Meet income guidelines** based on household size and Federal Poverty Level (FPL)—exact thresholds vary by medication and are listed on www.PAP.Novartis.com[2][3][5]. - Have a **valid prescription** from a licensed U.S. healthcare provider for outpatient treatment[2][5]. - Provide all required documentation; incomplete applications are delayed or denied[1][2][4]. **NPAF does not cover patients with alternative funding insurance** or those in institutional settings[1]. ## Income Eligibility Breakdown NPAF uses **Federal Poverty Level (FPL)** guidelines on a sliding scale, adjusted annually. Specific limits for **Arcapta Neohaler** are available at www.PAP.Novartis.com—check there first, as they depend on household size from your tax return[2][5]. Provide proof like the first 2 pages of your 1040 tax return (or 1099, W-2, pay stubs if not filing taxes)[1][5][7]. Here's a general example table of FPL-based thresholds (visit PAP site for current **Arcapta**-specific limits): | Household Size | Max Annual Income (e.g., 400-500% FPL)* | |----------------|-----------------------------------------| | 1 (Individual) | ~$60,000 - $75,000 | | 2 (Couple) | ~$81,000 - $101,000 | | 3 | ~$102,000 - $127,000 | | 4 | ~$123,000 - $153,000 | *Examples; confirm exact %FPL and amounts at www.PAP.Novartis.com. Household size matches your 1040 tax return[1][2][5]. If your income exceeds limits or you don't file taxes, call (800) 277-2254 for guidance[1]. ## Insurance Requirements - **No prescription coverage required**, but you must be **uninsured for prescriptions** or have coverage that doesn't pay for Novartis drugs[1][2][7]. - **Medicare Part D patients are ineligible**—program explicitly excludes them[1]. - Submit **front/back copies of ALL insurance cards** (primary, secondary, Rx), even if none[1][2][4]. - If insured with prior authorization (PA) denial or appeal outcome, include copies[1]. - No coverage from alternative funding programs that adjust based on PAP enrollment[1][3]. ## Step-by-Step Application Process NPAF offers **multiple application methods**: download forms online, call for help, then fax or mail[1][2][5]. Applications must be **complete**—missing info causes delays/denials[1][2][4]. 1. **Check Eligibility**: Visit www.PAP.Novartis.com or call (800) 277-2254 (Mon-Fri, 9am-6pm EST) to confirm **Arcapta Neohaler** qualifies and review income limits[2][3][4]. 2. **Gather Documents**: - Proof of income: First 2 pages of recent 1040, 1099, W-2, pay stubs[1][5][7]. - Insurance cards (front/back)[1][2]. - PA/appeal denials if applicable[1]. 3. **Complete Patient Section**: Fill personal info, household size, income, sign authorization (allows info sharing with doctor/NPAF)[1][2][9]. 4. **Doctor Completes HCP Section**: Provide valid **Arcapta Neohaler** prescription, medical info, sign authorizations[2][4][5]. 5. **Submit**: - **Fax**: 1-855-817-2711[1][2][4][5]. - **Mail**: Novartis Patient Assistance Foundation, Inc., PO Box 2529, Columbus, OH 43216 (or check form for latest PO Box)[1][5][9]. - Opt in for text updates[3]. Call (800) 277-2254 for forms or questions[1][4][5]. ## Timeline and Delivery - **Processing**: Up to **4 weeks** for decision letter (incomplete apps get 'next steps' letter + text)[3][5]. - If approved, medication ships **free** directly to you or your doctor's office (details in approval letter)[3][6]. Exact delivery method varies[3]. - **Annual review**: Eligibility checked yearly; reapply as needed[8]. ## Alternatives if Denied or Ineligible - **Appeal**: Contact NPAF at (800) 277-2254 if denied—provide missing info[6]. - **Other Novartis Programs**: Check www.novartis.com for copay cards, but NPAF is for uninsured[10]. - **General Resources**: RxAssist.org, NeedyMeds.org, or state programs. For Medicare, explore Extra Help (proof of denial may be needed)[3]. - **Discount Cards**: GoodRx for cash pay (~50-70% off retail). - **Patient Access Network (PAN) Foundation** or COPD-specific aid. If **Arcapta** unavailable, doctor may switch to similar LABAs like Serevent or Striverdi (check other PAPs). No biosimilars listed[ ]. ## Important Disclaimer This guide is for informational purposes based on publicly available NPAF details as of latest updates. **Eligibility, income limits, addresses, and terms can change**—always verify at www.PAP.Novartis.com or call (800) 277-2254. NPAF reserves right to modify/discontinue[3]. Not medical advice; consult your doctor. Free meds while supplies last; not guaranteed. Novartis not liable for application errors[1][3]. Word count: ~950.

Program information last verified: March 30, 2026